Kelly C. Lee, PharmD, MAS, BCPP, Richard J. Silvia, PharmD, BCPP, Gregory H. Payne, MBA, Tera D. Moore, PharmD, BCACP, Elayne D. Ansara, PharmD, BCPS, BCPP, Clint A. Ross, PharmD, BCPP

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements

Richard J. Silvia, PharmD, BCPP, Kelly C. Lee, PharmD, MAS, BCPP, Gregory H. Payne, MBA, Jessica Ho, PharmD, BCPS, BCPP, Carla Cobb, PharmD, BCPP, Elayne D. Ansara, PharmD, BCPS, BCPP, Clint A. Ross, PharmD, BCPP

Positioning psychiatric pharmacists to improve mental health care

Julie A. Dopheide, PharmD, BCPP, FASHP, Amy Werremeyer, PharmD, BCPP, Robert J. Haight, PharmD, BCPP, Cynthia A. Gutierrez, PharmD, MS, BCPP, Andrew M. Williams, PharmD, BCPP

CPNP 2022 Annual Meeting Poster Abstracts

Ambitious AAPP vision necessitates bold actions

Marshall E. Cates, PharmD, BCPP, FASHP, FCCP, FALSHP, Cherry W. Jackson, PharmD, FASHP, FCCP, BCPP

Issues

Examining the Impact of the Psychiatric Pharmacist, Vol. 5, Iss. 1

CPNP POSITION PAPER

Improving medication-related outcomes for patients with psychiatric and neurologic disorders: Value of psychiatric pharmacists as part of the health care team

ORIGINAL RESEARCH

Minimizing negative outcomes associated with potentially harmful lithium levels by means of pharmacist-led educational interventions in an inpatient psychiatric facility

Medication reconciliation improvement in a private psychiatric inpatient hospital

Redesigning the clinical pharmacy practice model at a psychiatric hospital

Re-implementation of a pharmacist-managed metabolic syndrome clinic in an outpatient mental health clinic setting

INNOVATIVE PRACTICE

Bridging the gap for patients with mental illness

Naloxone prescribing by psychiatric clinical pharmacists for patients receiving opioid agonist treatment

Cover Image

This Feature Is Available To Subscribers Only